Human immunodeficiency virus type 1 Tat accelerates kaposi sarcoma-associated herpesvirus kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice

Neoplasia

Volumn 11, Issue 12, 2009, Pages 1272-1284

  Chen, Xiuying ^a,b,c   Cheng, Lin ^a,d   Jia, Xuemei ^a   Zeng, Yi ^e   Yao, Shuihong ^a   Lv, Zhigang ^a   Qin, Di ^a   Fang, Xin ^a   Lei, Yongliang ^c   Lu, Chun ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Key Laboratory for Laboratory   (China)

^c Lishui Center for Disease Control and Prevention   (China)

^d HUANGHE SCIENCE AND TECHNOLOGY COLLEGE   (China)

^e YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; KAPOSIN A PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN; THYMIDINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN 3T3; COLONY FORMATION; DISEASE ASSOCIATION; FIBROBLAST; GENE EXPRESSION; GENETIC CODE; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOCOMPETENCE; IN VITRO STUDY; KAPOSI SARCOMA; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; ONCOGENE; OPEN READING FRAME; PATHOGENESIS; PRIMARY TUMOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 72949118092     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09494     Document Type: Article

References (46)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, and Moore PS (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869.
2. Biggar RJ, Rosenberg PS, and Cote T (1996). Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS.Multistate AIDS/CancerMatch Study Group. Int J Cancer 68, 754-758.
3. Ariyoshi K, Schim van der Loeff M, Cook P, Whitby D, Corrah T, Jaffar S, ChamF, Sabally S, O'Donovan D,Weiss RA, et al. (1998). Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1, 193-199.
4. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, andWong-Staal F (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345, 84-86.
5. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, and Gallo RC (1993). Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67, 277-287.
6. Ensoli B, Gendelman R,Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, and Gallo RC (1994). Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371, 674-680.
7. Fiorelli V, Gendelman R, Samaniego F, Markham PD, and Ensoli B (1995). Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 95, 1723-1734.
8. 3 integrin. J Immunol 163, 1929-1935.
9. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, and Ensoli B (1992). Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 66, 7159-7167.
10. Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, Qin D, Chen X, Tang Q, Lv Z, Zhang L, et al. (2007). Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol 81, 2401-2417.
11. Pyakurel P, Pak F, Mwakigonja AR, Kaaya E, and Biberfeld P (2007). KSHV/ HHV-8 and HIV infection in Kaposi's sarcoma development. Infect Agent Cancer 2, 4.
12. Tomkowicz B, Singh SP, Lai D, Singh A, Mahalingham S, Joseph J, Srivastava S, and Srinivasan A (2005). Mutational analysis reveals an essential role for the LXXLL motif in the transformation function of the human herpesvirus-8 onco-protein, kaposin. DNA Cell Biol 24, 10-20.
13. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, et al. (1997). Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71, 715-719.
14. Sturzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E, Ascherl G, Esser S, Brockmeyer NH, Ekman M, et al. (1997). Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 72, 68-71.
15. Linderoth J, Rambech E, and Dictor M (1999). Dominant human herpesvirus type 8 RNA transcripts in classical and AIDS-related Kaposi's sarcoma. J Pathol 187, 582-587.
16. Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B, and Ganem D (1999). A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpes-virus. J Virol 73, 5722-5730.
17. Muralidhar S, Pumfery AM, Hassani M, Sadaie MR, Kishishita M, Brady JN, Doniger J, Medveczky P, and Rosenthal LJ (1998). Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol 72, 4980-4988.
18. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, andMesri EA (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angio-genesis activator. Nature 391, 86-89.
19. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, and Gutkind JS (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res 60, 4873-4880.
20. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, Chensue SW, et al. (2000). Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191, 445-454.
21. Guo HG, Sadowska M, Reid W, Tschachler E, Hayward G, and Reitz M (2003). Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77, 2631-2639.
22. Guo HG, Pati S, Sadowska M, Charurat M, and Reitz M (2004). Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J Virol 78, 9336-9342.
23. McLemore ML, Grewal S, Liu F, Archambault A, Poursine-Laurent J, Haug J, and Link DC (2001). STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14, 193-204.
24. Lu C, Zeng Y, Huang Z, Huang L, Qian C, Tang G, and Qin D (2005). Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpes-virus. Am J Pathol 166, 173-183.
25. Qin D, Zeng Y, Qian C, Huang Z, Lv Z, Cheng L, Yao S, Tang Q, Chen X, and Lu C (2008). Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cell Microbiol 10, 713-728.
26. Yao S, Tang Q, Cheng L, Zeng Y, Chen X, Qin D, Lv Z, and Lu C (2007). Identification of B cell epitopes at the C-terminus of latency-associated nuclear protein of the Kaposi's sarcoma-associated herpesvirus. Acta Virol 51, 109-118.
27. Kolble K, Ullrich OM, Pidde H, Barthel B, Diermann J, Rudolph B, Dietel M, Schlag PM, and Scherneck S (1999). Microsatellite alterations in serum DNA of patients with colorectal cancer. Lab Invest 79, 1145-1150.
28. Kim D, Cheng GZ, Lindsley CW, Yang H, and Cheng JQ (2005). Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. Curr Opin Investig Drugs 6, 1250-1258.
29. Luo J, Manning BD, and Cantley LC (2003). Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257-262.
30. lck. J Virol 71, 6677-6682.
31. Migone TS, Lin JX, Cereseto A,Mulloy JC, O'Shea JJ, Franchini G, and Leonard WJ (1995). Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269, 79-81.
32. Chen H, Hutt-Fletcher L, Cao L, and Hayward SD (2003). A positive auto-regulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol 77, 4139-4148.
33. Barillari G, Gendelman R, Gallo RC, and Ensoli B (1993). The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 90, 7941-7945.
34. Harrington W Jr, Sieczkowski L, Sosa C, Chan-a-Sue S, Cai JP, Cabral L, and Wood C (1997). Activation of HHV-8 by HIV-1 tat. Lancet 349, 774-775.
35. Aoki Y and Tosato G (2004). HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood 104, 810-814.
36. Kliche S, Nagel W, Kremmer E, Atzler C, Ege A, Knorr T, Koszinowski U, Kolanus W, and Haas J (2001). Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol Cell 7, 833-843.
37. Muralidhar S, Veytsmann G, Chandran B, Ablashi D, Doniger J, and Rosenthal LJ (2000). Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J Clin Virol 16, 203-213.
38. Tomkowicz B, Singh SP, Cartas M, and Srinivasan A (2002). Human herpes-virus-8 encoded Kaposin: subcellular localization using immunofluorescence and biochemical approaches. DNA Cell Biol 21, 151-162.
39. Blauvelt A (1999). The role of human herpesvirus 8 in the pathogenesis of Kaposi's sarcoma. Adv Dermatol 14, 167-206; discussion 207.
40. Martin JC and Bandres JC (1999). Cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infection. J Acquir Immune Defic Syndr 22, 413-429.
41. Weiss RA (2000). Getting to know HIV. Trop Med Int Health 5, A10-A15.
42. Selby MJ, Bain ES, Luciw PA, and Peterlin BM (1989). Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev 3, 547-558.
43. Pati S, Foulke JS Jr, Barabitskaya O, Kim J, Nair BC, Hone D, Smart J, Feldman RA, and Reitz M (2003). Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immuno-deficiency virus type 1 Tat. J Virol 77, 5759-5773.
44. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, and Graeve L (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334 (Pt 2), 297-314.
45. Thirunarayanan N, Cifire F, Fichtner I, Posner S, Benga J, Reiterer P, Kremmer E, Kolble K, and LippM(2007). Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice. Oncogene 26, 5702-5712.
46. Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U,Hermans J,Hemmi S, Hengartner H, and Zinkernagel RM (2001). Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411, 1058-1064.